Lipocine Inc. financial data

Symbol
LPCN on Nasdaq
Industry
Pharmaceutical Preparations
Location
675 Arapeen Drive, Suite 202, Salt Lake City, X1
State of incorporation
Delaware
Fiscal year end
December 31
Former names
MARATHON BAR CORP (to 7/9/2013)
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.17K % -36.5%
Debt-to-equity 9.34 % +62.7%
Return On Equity -38.6 % -7.02%
Return On Assets -35.3 % -3.49%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.35M shares +0.6%
Common Stock, Shares, Outstanding 5.35M shares +2.16%
Entity Public Float 25.6M USD -63%
Common Stock, Value, Issued 8.86K USD +0.12%
Weighted Average Number of Shares Outstanding, Basic 5.34M shares +2.08%
Weighted Average Number of Shares Outstanding, Diluted 5.34M shares +2.08%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 89.6K USD
Revenue from Contract with Customer, Excluding Assessed Tax 55K USD
Research and Development Expense 9.25M USD -1.55%
General and Administrative Expense 5.26M USD +19.1%
Operating Income (Loss) -9.71M USD +29.4%
Nonoperating Income (Expense) 1.22M USD -44.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -8.49M USD +29.6%
Income Tax Expense (Benefit) 481 USD
Net Income (Loss) Attributable to Parent -8.49M USD +29.6%
Earnings Per Share, Basic -1.59 USD/shares +45.9%
Earnings Per Share, Diluted -1.6 USD/shares +45.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.55M USD +10.7%
Assets, Current 22.9M USD -15.4%
Property, Plant and Equipment, Net 99.1K USD -19.2%
Other Assets, Noncurrent 23.8K USD 0%
Assets 23M USD -24.4%
Accounts Payable, Current 449K USD -13.3%
Accrued Liabilities, Current 1.23M USD -5.81%
Liabilities, Current 1.82M USD -0.18%
Liabilities 1.82M USD -5.57%
Accumulated Other Comprehensive Income (Loss), Net of Tax -9.72K USD +38.5%
Retained Earnings (Accumulated Deficit) -199M USD -4.45%
Stockholders' Equity Attributable to Parent 21.2M USD -25.7%
Liabilities and Equity 23M USD -24.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 2.41M USD
Net Cash Provided by (Used in) Financing Activities -6.02M USD -859%
Net Cash Provided by (Used in) Investing Activities -4.09M USD -174%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 5.35M shares +2.16%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.69M USD -204%
Interest Paid, Excluding Capitalized Interest, Operating Activities 14.9K USD -70.5%
Deferred Tax Assets, Valuation Allowance 47.8M USD +4.14%
Deferred Tax Assets, Gross 47.8M USD +4.13%
Payments to Acquire Property, Plant, and Equipment 4K USD -85.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -8.48M USD +29.3%
Lessee, Operating Lease, Liability, to be Paid 245K USD +3%
Property, Plant and Equipment, Gross 1.3M USD +1.03%
Lessee, Operating Lease, Liability, to be Paid, Year Two 61.3K USD +3%
Lessee, Operating Lease, Liability, to be Paid, Year One 61.3K USD +3%
Preferred Stock, Shares Issued 88.5K shares
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 221M USD +0.52%
Preferred Stock, Shares Outstanding 88.5K shares
Interest Expense 104K USD -64.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%